It is a research & development private limited company based in Navi Mumbai, Maharashtra, India, established in 2004.
2004 | Navi Mumbai, Maharashtra, India | AmalgamatedHexal Pharma Private Limited, a amalgamated private limited company, was established on 15 April 2004 in Navi Mumbai, Maharashtra, India. Engaging in science research within the research & development sector, it holds CIN: U73100MH2004PTC169592. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.85 Cr.
Its leadership includes Vijay Nagesh Vedak (Director), Gerhard Otto Schaefer (Director), Govindarajan Venkatachary (Director). Past directors included Suresh Gobindram Advani. Its latest AGM occurred on 21 September 2010, with the balance sheet filed on 31 March 2010. It is based at Midc, Plot No. 8-A/2, 8-B, Ttc Industrial Area, Kalwe Block, Village Dighe,, Navi Mumbai, Maharashtra, 400708.
U73100MH2004PTC169592
169592
15 April 2004
₹2.00 Cr
₹1.85 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Hexal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Nagesh Vedak | Director | 19 Aug 2005 | Current |
| Gerhard Otto Schaefer | Director | 21 Apr 2004 | Current |
| Govindarajan Venkatachary | Director | 19 Aug 2005 | Current |
| Andreas Strungmann | Director | 21 Apr 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Aug 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Hexal Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Hexal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hexal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hexal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hexal Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hexal Pharma Private Limited last Annual general meeting of members was held on 21 Sep 2010 as per latest MCA records. was recorded as a recent event.
The activity Hexal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Mumbai. was completed.
Vijay Nagesh Vedak was appointed as a Director was appointed as a Director on 19 Aug 2005 & has been associated with this company since 20 years 4 months . was recorded as a recent event.
The activity Govindarajan Venkatachary was appointed as a Director was appointed as a Director on 19 Aug 2005 & has been associated with this company since 20 years 4 months . was completed.
Progress on Gerhard Otto Schaefer was appointed as a Director was appointed as a Director on 21 Apr 2004 & has been associated with this company since 21 years 8 months . was documented.
Progress on Andreas Strungmann was appointed as a Director was appointed as a Director on 21 Apr 2004 & has been associated with this company since 21 years 8 months . was documented.
The CIN of Hexal Pharma Private Limited is U73100MH2004PTC169592.
Hexal Pharma Private Limited is headquartered at Midc, Plot No. 8-A/2, 8-B, Ttc Industrial Area, Kalwe Block, Village Dighe,, Navi Mumbai, Maharashtra, 400708.
Hexal Pharma Private Limited was incorporated on 15 April 2004.
The current directors of Hexal Pharma Private Limited are
The primary industry of Hexal Pharma Private Limited is Research & Development.
Hexal Pharma Private Limited is unlisted.
The authorized capital of Hexal Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.85 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX